Trxade Group Inc (MEDS) — Cash Flow-to-Debt Ratio
Trxade Group Inc (MEDS) has a Cash Flow-to-Debt Ratio of 1.38x as of June 2024, meaning its operating cash flow of $4.22 Million could theoretically repay 1% of its total liabilities ($3.06 Million) in one year. Check Trxade Group Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Trxade Group Inc Cash Flow-to-Debt Ratio (2006–2023)
Historical debt coverage capacity for Trxade Group Inc across 15 annual periods. Check Trxade Group Inc (MEDS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Annual Cash Flow-to-Debt Ratio for Trxade Group Inc (2006–2023)
Year-by-year debt coverage analysis for Trxade Group Inc. For the full cash flow conversion analysis, see MEDS operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.17x | $-2.07 Million | $11.99 Million | ▲ +61.8% |
| 2022 | -0.45x | $-1.53 Million | $3.37 Million | ▲ +64.8% |
| 2021 | -1.29x | $-2.57 Million | $2.00 Million | ▲ +35.4% |
| 2020 | -1.99x | $-2.21 Million | $1.11 Million | ▼ -2107.9% |
| 2019 | 0.10x | $141.78K | $1.43 Million | ▼ -49.9% |
| 2018 | 0.20x | $273.39K | $1.38 Million | ▲ +7.0% |
| 2017 | 0.18x | $171.67K | $929.41K | ▲ +120.9% |
| 2016 | -0.88x | $-1.31 Million | $1.49 Million | ▼ -29.5% |
| 2015 | -0.68x | $-1.20 Million | $1.76 Million | ▲ +64.5% |
| 2014 | -1.92x | $-1.06 Million | $553.68K | ▲ +37.8% |
| 2013 | -3.09x | $-844.58K | $273.00K | ▼ -91.9% |
| 2012 | -1.61x | $-163.12K | $101.19K | ▼ -178.7% |
| 2008 | -0.58x | $-28.16 Million | $48.70 Million | ▲ +27.0% |
| 2007 | -0.79x | $-16.07K | $20.28K | ▲ +55.5% |
| 2006 | -1.78x | $-6.22K | $3.50K | — |